e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Clinical parameters in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma control test: Cut off values of control according to GINA guideline and its ability to predict exacerbations and treatment decisions
F. W. S. Ko, D. S. C. Hui, T. F. Leung, J. H. Y. Chu, G. W. K. Wong, S. S. S. Ng, C. K. W. Lai (HK, Hong Kong)
Source:
Annual Congress 2011 - Clinical parameters in airway diseases
Session:
Clinical parameters in airway diseases
Session type:
Thematic Poster Session
Number:
940
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. W. S. Ko, D. S. C. Hui, T. F. Leung, J. H. Y. Chu, G. W. K. Wong, S. S. S. Ng, C. K. W. Lai (HK, Hong Kong). Asthma control test: Cut off values of control according to GINA guideline and its ability to predict exacerbations and treatment decisions. Eur Respir J 2011; 38: Suppl. 55, 940
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Can asthma control test (ACT) replace a global assessment of asthma control according to GINA guidelines?
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Can we achieve GINA guidelines described asthma control in a developing country?
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Assessing asthma control: asthma control questionnaire score versus a scoring system based on GINA
Source: Eur Respir J 2004; 24: Suppl. 48, 460s
Year: 2004
Comparative assessment of asthma control test and GINA classification in predicting asthma severity
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II
Year: 2007
Agreement between asthma control perception by patients, by physicians and according to guidelines
Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Year: 2011
Omalizumab added to best standard care reduces exacerbations in patients with severe persistent asthma according to GINA 2002 classification
Source: Eur Respir J 2004; 24: Suppl. 48, 220s
Year: 2004
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
Control of asthma at the 3rd-line pulmonary diseases clinics (3rd line pdc) according GINA (global initiative for asthma) parameters
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Concordance between Asthma Control Test and the revised GINA criteria of asthma control
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Global strategy for asthma management and prevention: GINA executive summary
Source: Eur Respir J 2008; 31: 143-178
Year: 2008
Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
A new perspective on concepts of asthma severity and control
Source: Eur Respir J 2008; 32: 545-554
Year: 2008
A summary of the new GINA strategy: a roadmap to asthma control
Source: Eur Respir J 2015; 46: 622-639
Year: 2015
Validation of the asthma control questionnaire (ACQ): results from the gaining optimal asthma control (GOAL) study
Source: Annual Congress 2004 - Asthma and perceived health status
Year: 2004
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
How to measure asthma control? Asthma control questionnaire versus expert system
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001
COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The application of GINA guidelines results in a reduced number of exacerbations in asthmatic patients
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009
Lack of agreement between GINA guidelines and physician assessment of asthma severity
Source: Eur Respir J 2004; 24: Suppl. 48, 591s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept